The global hyperphosphatemia drugs market is growing due to rising CKD prevalence, innovative phosphate binders like tenapanor, and expanding online pharmacies, enhancing access and patient adherence. More Info: https://www.imarcgroup.com/hyperphosphatemia-drugs-market